An analysis of the rewarding and aversive associative properties of nicotine in the neonatal quinpirole model: Effects on glial cell line-derived neurotrophic factor (GDNF)

被引:10
|
作者
Brown, Russell W. [1 ]
Kirby, Seth L. [2 ]
Denton, Adam R. [2 ]
Dose, John M. [3 ]
Cummins, Elizabeth D. [2 ]
Gill, Wesley Drew [1 ]
Burgess, Katherine C. [1 ]
机构
[1] East Tennessee State Univ, James H Quillen Coll Med, Dept Biomed Sci, Johnson City, TN 37614 USA
[2] East Tennessee State Univ, Dept Psychol, Johnson City, TN 37614 USA
[3] St Norbert Coll, Dept Psychol, De Pere, WI 54115 USA
关键词
Dopamine D2 receptor; Schizophrenia; Adolescence; Nicotine; Antipsychotics; Conditioned place preference; CONDITIONED PLACE PREFERENCE; CUE-INDUCED REINSTATEMENT; VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; ANTIPSYCHOTIC-DRUGS; DOPAMINE ANTAGONISTS; PARKINSONS-DISEASE; LOCOMOTOR-ACTIVITY; SEEKING BEHAVIOR; RATS;
D O I
10.1016/j.schres.2017.03.024
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
This study analyzed the associative properties of nicotine in a conditioned place preference (CPP) paradigm in adolescent rats neonatally treated with quinpirole (NQ) or saline (NS). NQ produces dopamine D2 receptor super-sensitivity that persists throughout the animal's lifetime, and therefore has relevance towards schizophrenia. In two experiments, rats were ip administered quinpirole (1 mg/kg) or saline from postnatal day (P) 1-21. After an initial preference test at P42-43, animals were conditioned for eight consecutive days with saline or nicotine (0.6 mg/kg free base) in Experiment 1 or saline or nicotine (1.8 mg/kg free base) in Experiment 2. In addition, there were NQ and NS groups in each experiment given the antipsychotic haloperidol (0.05mg/kg) or clozapine (2.5 mg/kg) before nicotine conditioning. A drug free post-conditioning testwas administered at P52. At P53, the nucleus accumbens (NAc) was analyzed for glial cell-line derived neurotrophic factor (GDNF). Results revealed that NQ enhanced nicotine CPP, but blunted the aversive properties of nicotine. Haloperidol was more effective than clozapine at blocking nicotine CPP in Experiment 1, but neither antipsychotic affected nicotine conditioned place aversion in Experiment 2. NQ increased accumbal GDNF which was sensitized in NQ rats conditioned to nicotine in Experiment 1, but the aversive dose of nicotine reduced GDNF in NQ animals in Experiment 2. Both antipsychotics in combination with the aversive dose of nicotine decreased accumbal GDNF. In sum, increased D2 receptor sensitivity influenced the associative properties and GDNF response to nicotine which has implications towards pharmacological targets for smoking cessation in schizophrenia. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:107 / 114
页数:8
相关论文
共 50 条
  • [21] Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential
    Y. A. Sidorova
    M. Saarma
    Molecular Biology, 2016, 50 : 521 - 531
  • [22] Glial cell line-derived neurotrophic factor family ligands and their therapeutic potential
    Sidorova, Y. A.
    Saarma, M.
    MOLECULAR BIOLOGY, 2016, 50 (04) : 521 - 531
  • [23] Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor
    Camicella, Sebastien
    Amamoto, Ryoji
    Ron, Dorit
    ALCOHOL, 2009, 43 (01) : 35 - 43
  • [24] Glial Cell Line-Derived Neurotrophic Factor (GDNF) serum level in women with schizophrenia and depression, correlation with clinical and metabolic parameters
    Skibinska, Maria
    Kapelski, Pawel
    Pawlak, Joanna
    Rajewska-Rager, Aleksandra
    Dmitrzak-Weglarz, Monika
    Szczepankiewicz, Aleksandra
    Czerski, Piotr
    Twarowska-Hauser, Joanna
    PSYCHIATRY RESEARCH, 2017, 256 : 396 - 402
  • [25] Effects of glial cell line-derived neurotrophic factor deletion on ventral mesencephalic organotypic tissue cultures
    af Bjerken, Sara
    Boger, Heather A.
    Nelson, Matthew
    Hoffer, Barry J.
    Granholm, Ann-Charlotte
    Stromberg, Ingrid
    BRAIN RESEARCH, 2007, 1133 (01) : 10 - 19
  • [26] Astrocyte delivery of glial cell line-derived neurotrophic factor in a mouse model of Parkinson's disease
    Cunningham, LA
    Su, C
    EXPERIMENTAL NEUROLOGY, 2002, 174 (02) : 230 - 242
  • [27] Extended Treatment with Glial Cell Line-Derived Neurotrophic Factor in Parkinson's Disease
    Whone, Alan L.
    Boca, Mihaela
    Luz, Matthias
    Woolley, Max
    Mooney, Lucy
    Dharia, Sonali
    Broadfoot, Jack
    Cronin, David
    Schroers, Christian
    Barua, Neil U.
    Longpre, Lara
    Barclay, C. Lynn
    Boiko, Chris
    Johnson, Greg A.
    Fibiger, H. Christian
    Harrison, Rob
    Lewis, Owen
    Pritchard, Gemma
    Howell, Mike
    Irving, Charlie
    Johnson, David
    Kinch, Suk
    Marshall, Christopher
    Lawrence, Andrew D.
    Blinder, Stephan
    Sossi, Vesna
    Stoessl, A. Jon
    Skinner, Paul
    Mohr, Erich
    Gill, Steven S.
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (02) : 301 - 313
  • [28] Glial cell line-derived neurotrophic factor (GDNF) as a defensive molecule for neurodegenerative disease: a tribute to the studies of Antonia Vernadakis on neuronal-glial interactions
    Bohn, MC
    Kozlowski, DA
    Connor, B
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2000, 18 (07) : 679 - 684
  • [29] Glial Cell Line-Derived Neurotrophic Factor Reverses Alcohol-Induced Allostasis of the Mesolimbic Dopaminergic System: Implications for Alcohol Reward and Seeking
    Barak, Segev
    Carnicella, Sebastien
    Yowell, Quinn V.
    Ron, Dorit
    JOURNAL OF NEUROSCIENCE, 2011, 31 (27) : 9885 - 9894
  • [30] Protective effect of the glial cell line-derived neurotrophic factor (GDNF) on human mesencephalic neuron-derived cells against neurotoxicity induced by paraquat
    Ortiz-Ortiz, Miguel A.
    Moran, Jose M.
    Ruiz-Mesa, Luz M.
    Guerrero Bonmatty, Rafael
    Fuentes, Jose M.
    ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY, 2011, 31 (01) : 129 - 136